Literature DB >> 3102446

Intrinsic antibiotic resistance of Pseudomonas aeruginosa.

R E Hancock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3102446     DOI： 10.1093/jac/18.6.653

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  12 in total

1.  Sequence and transcriptional start site of the Pseudomonas aeruginosa outer membrane porin protein F gene.

Authors:  M Duchêne; A Schweizer; F Lottspeich; G Krauss; M Marget; K Vogel; B U von Specht; H Domdey
Journal:  J Bacteriol       Date:  1988-01       Impact factor: 3.490

2.  Physiological studies of the regulation of beta-lactamase expression in Pseudomonas maltophilia.

Authors:  S Rosta; H Mett
Journal:  J Bacteriol       Date:  1989-01       Impact factor: 3.490

Review 3.  Perspectives on the potential for successful development of outer membrane protein vaccines.

Authors:  H E Gilleland; J M Matthews-Greer
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

Review 4.  Mechanisms of resistance to cephalosporin antibiotics.

Authors:  D M Livermore
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Cationic fullerenes are effective and selective antimicrobial photosensitizers.

Authors:  George P Tegos; Tatiana N Demidova; Dennisse Arcila-Lopez; Haeryeon Lee; Tim Wharton; Hariprasad Gali; Michael R Hamblin
Journal:  Chem Biol       Date:  2005-10

6.  Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning, sequence, and expression in Escherichia coli.

Authors:  M Duchêne; C Barron; A Schweizer; B U von Specht; H Domdey
Journal:  J Bacteriol       Date:  1989-08       Impact factor: 3.490

7.  Determinants of the efficacy of tobramycin therapy against isogenic nonmucoid and mucoid derivatives of Pseudomonas aeruginosa PAO1 growing in peritoneal chambers in mice.

Authors:  N M Kelly; E G Rawling; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

8.  Protection of immunosuppressed mice against infection with pseudomonas aeruginosa by monoclonal antibodies to outer membrane protein OprI.

Authors:  R Rahner; A Eckhardt; M Duchêne; H Domdey; B U von Specht
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

9.  Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.

Authors:  R A Celesk; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.

Authors:  B U von Specht; B Knapp; G Muth; M Bröker; K D Hungerer; K D Diehl; K Massarrat; A Seemann; H Domdey
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.